Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact firstname.lastname@example.org.
Characteristics of Peripheral Lymphocyte Subset Alteration in 2019-nCoV Pneumonia
21 Pages Posted: 24 Feb 2020More...
Background: Since December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCP) occurred in Wuhan, and rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in NCP.
Methods: The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 NCP patients before and after treatment, and their association with clinical characteristics and efficacy was analyzed.
Findings: Compared to healthy controls, NCP patients had a significant decrease of total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells. In NCP patients, severe cases had a lower level of CD4+ T cells and CD8+ T cells than mild cases. CD8+ T cell levels were negatively correlated with inflammatory indicators of erythrocyte sedimentation rat (ESR), C-reactive protein (CRP) and interleukin-6 (IL-6), while CD4+/CD8+ ratio was positively correlated. Levels of total lymphocytes and CD4+ T cells were negatively correlated with ESR, and NK cells in negative correlation with IL-6. After one-week treatment, 37 patients (67%) reached clinical response, and had a significant increase of total lymphocytes, CD8+ T cells and B cells. In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor clinical efficacy.
Interpretation: Peripheral lymphocyte subset alteration demonstrated a significant association with the clinical characteristics and efficacy of NCP. CD8+ T cells tended to be an independent predictor for NCP severity and treatment efficacy.
Funding Statement: This study was supported by the Program of Excellent Doctoral (Postdoctoral) of Zhongnan Hospital of Wuhan University (Grant No. ZNYB2019003).
Declaration of Interests: The authors declared no competing interests.
Ethics Approval Statement: This study was approved by the ethics committee of Zhongnan Hospital of Wuhan University (No. 2020011). Written informed consent was obtained from patients.
Keywords: 2019 novel coronavirus; pneumonia; lymphocyte subset
Suggested Citation: Suggested Citation